nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—SRC—adrenal medulla—adrenal gland cancer	0.183	0.488	CbGeAlD
Trabectedin—CYP2C19—urine—adrenal gland cancer	0.0351	0.0938	CbGeAlD
Trabectedin—CYP2C9—urine—adrenal gland cancer	0.0272	0.0727	CbGeAlD
Trabectedin—CYP2E1—urine—adrenal gland cancer	0.0258	0.0689	CbGeAlD
Trabectedin—CYP3A4—urine—adrenal gland cancer	0.0208	0.0554	CbGeAlD
Trabectedin—CYP2D6—urine—adrenal gland cancer	0.0204	0.0546	CbGeAlD
Trabectedin—SRC—gonad—adrenal gland cancer	0.0146	0.039	CbGeAlD
Trabectedin—SRC—cardiac atrium—adrenal gland cancer	0.0146	0.039	CbGeAlD
Trabectedin—SRC—adrenal gland—adrenal gland cancer	0.0127	0.034	CbGeAlD
Trabectedin—PTGS1—cardiac atrium—adrenal gland cancer	0.00545	0.0145	CbGeAlD
Trabectedin—PTGS1—pituitary gland—adrenal gland cancer	0.00532	0.0142	CbGeAlD
Trabectedin—CYP2E1—adrenal gland—adrenal gland cancer	0.00494	0.0132	CbGeAlD
Trabectedin—PTGS1—adrenal gland—adrenal gland cancer	0.00475	0.0127	CbGeAlD
Trabectedin—PTGS1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00179	0.00286	CbGpPWpGaD
Trabectedin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00176	0.00281	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—PRKACA—adrenal gland cancer	0.00175	0.00279	CbGpPWpGaD
Trabectedin—SRC—CXCR4-mediated signaling events—BAD—adrenal gland cancer	0.00174	0.00278	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—PRKACA—adrenal gland cancer	0.00174	0.00278	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—CDC42—adrenal gland cancer	0.00174	0.00277	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00173	0.00276	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—PRKACA—adrenal gland cancer	0.00173	0.00276	CbGpPWpGaD
Trabectedin—SRC—Internalization of ErbB1—EGFR—adrenal gland cancer	0.00171	0.00273	CbGpPWpGaD
Trabectedin—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00165	0.00264	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by TCPTP—EGFR—adrenal gland cancer	0.00164	0.00262	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—NR5A1—adrenal gland cancer	0.00162	0.0026	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—CDC42—adrenal gland cancer	0.00162	0.00259	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—PRKACA—adrenal gland cancer	0.00162	0.00259	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—BRAF—adrenal gland cancer	0.00161	0.00258	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.0016	0.00257	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—PRKACA—adrenal gland cancer	0.0016	0.00256	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—PRKACA—adrenal gland cancer	0.00159	0.00254	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—RB1—adrenal gland cancer	0.00159	0.00254	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—PRKACA—adrenal gland cancer	0.00158	0.00253	CbGpPWpGaD
Trabectedin—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—adrenal gland cancer	0.00158	0.00252	CbGpPWpGaD
Trabectedin—SRC—GAB1 signalosome—BAD—adrenal gland cancer	0.00149	0.00238	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—RB1—adrenal gland cancer	0.00149	0.00237	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—CDC42—adrenal gland cancer	0.00147	0.00236	CbGpPWpGaD
Trabectedin—SRC—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.00147	0.00235	CbGpPWpGaD
Trabectedin—SRC—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.00147	0.00235	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—SH3KBP1—adrenal gland cancer	0.00146	0.00234	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—BAD—adrenal gland cancer	0.00145	0.00233	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—PRKACA—adrenal gland cancer	0.00143	0.00229	CbGpPWpGaD
Trabectedin—SRC—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—adrenal gland cancer	0.00142	0.00227	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—CDKN2A—adrenal gland cancer	0.00139	0.00223	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TERT—adrenal gland cancer	0.00139	0.00223	CbGpPWpGaD
Trabectedin—SRC—Integrin-mediated Cell Adhesion—BRAF—adrenal gland cancer	0.00138	0.0022	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—adrenal gland cancer	0.00137	0.00219	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—CDC42—adrenal gland cancer	0.00136	0.00217	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—adrenal gland cancer	0.00135	0.00217	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—CDC42—adrenal gland cancer	0.00135	0.00216	CbGpPWpGaD
Trabectedin—CYP2E1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00134	0.00214	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by PTP1B—EGFR—adrenal gland cancer	0.00133	0.00213	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—BRAF—adrenal gland cancer	0.00132	0.00212	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—BRAF—adrenal gland cancer	0.00132	0.00212	CbGpPWpGaD
Trabectedin—SRC—CDC42 signaling events—CTNNB1—adrenal gland cancer	0.00132	0.00212	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—RB1—adrenal gland cancer	0.0013	0.00208	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—CDC42—adrenal gland cancer	0.0013	0.00207	CbGpPWpGaD
Trabectedin—PTGS1—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.00129	0.00207	CbGpPWpGaD
Trabectedin—SRC—ErbB Signaling Pathway—EGFR—adrenal gland cancer	0.00129	0.00206	CbGpPWpGaD
Trabectedin—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00127	0.00203	CbGpPWpGaD
Trabectedin—SRC—Thromboxane A2 receptor signaling—EGFR—adrenal gland cancer	0.00125	0.002	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00121	0.00194	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—IGF1R—adrenal gland cancer	0.00121	0.00193	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CTNNB1—adrenal gland cancer	0.00119	0.0019	CbGpPWpGaD
Trabectedin—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00117	0.00188	CbGpPWpGaD
Trabectedin—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00117	0.00187	CbGpPWpGaD
Trabectedin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00116	0.00185	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—BRAF—adrenal gland cancer	0.00115	0.00184	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00115	0.00184	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—BAD—adrenal gland cancer	0.00115	0.00184	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—CDKN2A—adrenal gland cancer	0.00114	0.00183	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—BAD—adrenal gland cancer	0.00113	0.00181	CbGpPWpGaD
Trabectedin—SRC—LPA receptor mediated events—EGFR—adrenal gland cancer	0.00113	0.0018	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.00111	0.00177	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—PRKACA—adrenal gland cancer	0.0011	0.00176	CbGpPWpGaD
Trabectedin—SRC—AGE/RAGE pathway—EGFR—adrenal gland cancer	0.0011	0.00176	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—CTNNB1—adrenal gland cancer	0.00109	0.00175	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—EGFR—adrenal gland cancer	0.00109	0.00174	CbGpPWpGaD
Trabectedin—SRC—ErbB Signaling Pathway—TP53—adrenal gland cancer	0.00108	0.00173	CbGpPWpGaD
Trabectedin—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00107	0.00171	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—BAD—adrenal gland cancer	0.00103	0.00165	CbGpPWpGaD
Trabectedin—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00103	0.00165	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—BAD—adrenal gland cancer	0.00103	0.00164	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—BAD—adrenal gland cancer	0.00102	0.00164	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MED12—adrenal gland cancer	0.000976	0.00156	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—BAD—adrenal gland cancer	0.000958	0.00153	CbGpPWpGaD
Trabectedin—PTGS1—Biological oxidations—POMC—adrenal gland cancer	0.00095	0.00152	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—BAD—adrenal gland cancer	0.000949	0.00152	CbGpPWpGaD
Trabectedin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000948	0.00152	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—CTNNB1—adrenal gland cancer	0.000943	0.00151	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—BAD—adrenal gland cancer	0.000941	0.0015	CbGpPWpGaD
Trabectedin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00094	0.0015	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—BAD—adrenal gland cancer	0.000937	0.0015	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—BRAF—adrenal gland cancer	0.000936	0.0015	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—BRAF—adrenal gland cancer	0.000936	0.0015	CbGpPWpGaD
Trabectedin—SRC—Oncostatin M Signaling Pathway—TP53—adrenal gland cancer	0.000934	0.00149	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—EGFR—adrenal gland cancer	0.000924	0.00148	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000916	0.00146	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—TP53—adrenal gland cancer	0.000912	0.00146	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—BAD—adrenal gland cancer	0.000905	0.00145	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000901	0.00144	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—CTNNB1—adrenal gland cancer	0.00089	0.00142	CbGpPWpGaD
Trabectedin—SRC—Immune System—SH3KBP1—adrenal gland cancer	0.000888	0.00142	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—BRAF—adrenal gland cancer	0.000872	0.00139	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—EGFR—adrenal gland cancer	0.000865	0.00138	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—SDHB—adrenal gland cancer	0.000849	0.00136	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	0.000848	0.00136	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—CDC42—adrenal gland cancer	0.000846	0.00135	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—SPARC—adrenal gland cancer	0.000827	0.00132	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—BRAF—adrenal gland cancer	0.000824	0.00132	CbGpPWpGaD
Trabectedin—SRC—Disease—SH3KBP1—adrenal gland cancer	0.00082	0.00131	CbGpPWpGaD
Trabectedin—SRC—L1CAM interactions—EGFR—adrenal gland cancer	0.000814	0.0013	CbGpPWpGaD
Trabectedin—SRC—Cell-Cell communication—CTNNB1—adrenal gland cancer	0.000807	0.00129	CbGpPWpGaD
Trabectedin—SRC—GAB1 signalosome—EGFR—adrenal gland cancer	0.000776	0.00124	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—TP53—adrenal gland cancer	0.000776	0.00124	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	0.000772	0.00123	CbGpPWpGaD
Trabectedin—SRC—Disease—ZNRF3—adrenal gland cancer	0.000771	0.00123	CbGpPWpGaD
Trabectedin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000765	0.00122	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—EGFR—adrenal gland cancer	0.000758	0.00121	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.000743	0.00119	CbGpPWpGaD
Trabectedin—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	0.00071	0.00113	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—PRKACA—adrenal gland cancer	0.000698	0.00112	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000668	0.00107	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000663	0.00106	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—BAD—adrenal gland cancer	0.000652	0.00104	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—TP53—adrenal gland cancer	0.000637	0.00102	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—SDHB—adrenal gland cancer	0.000635	0.00101	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PRKACA—adrenal gland cancer	0.000629	0.00101	CbGpPWpGaD
Trabectedin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00062	0.000991	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—GNRHR—adrenal gland cancer	0.000618	0.000988	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—CDC42—adrenal gland cancer	0.000604	0.000965	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PRKACA—adrenal gland cancer	0.000604	0.000965	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—EGFR—adrenal gland cancer	0.000599	0.000957	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—CTNNB1—adrenal gland cancer	0.000595	0.000952	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—BRAF—adrenal gland cancer	0.000594	0.00095	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000593	0.000948	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—CDC42—adrenal gland cancer	0.000592	0.000947	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000574	0.000918	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—IGF2—adrenal gland cancer	0.000571	0.000913	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—GNAS—adrenal gland cancer	0.000566	0.000905	CbGpPWpGaD
Trabectedin—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.000548	0.000876	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—SDHD—adrenal gland cancer	0.000547	0.000875	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—RRM1—adrenal gland cancer	0.000547	0.000875	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00054	0.000863	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—EGFR—adrenal gland cancer	0.000539	0.000861	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—EGFR—adrenal gland cancer	0.000536	0.000857	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—EGFR—adrenal gland cancer	0.000536	0.000857	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—EGFR—adrenal gland cancer	0.000533	0.000853	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CDC42—adrenal gland cancer	0.000533	0.000853	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TP53—adrenal gland cancer	0.00053	0.000847	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000528	0.000844	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CDC42—adrenal gland cancer	0.000512	0.000819	CbGpPWpGaD
Trabectedin—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.000504	0.000805	CbGpPWpGaD
Trabectedin—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.000499	0.000798	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—EGFR—adrenal gland cancer	0.000499	0.000798	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—EGFR—adrenal gland cancer	0.000495	0.000791	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	0.00049	0.000784	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.00049	0.000783	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—EGFR—adrenal gland cancer	0.000488	0.000781	CbGpPWpGaD
Trabectedin—SRC—Disease—SPRY2—adrenal gland cancer	0.000483	0.000773	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000482	0.00077	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—EGFR—adrenal gland cancer	0.000472	0.000754	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.00047	0.000751	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.00045	0.00072	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000446	0.000714	CbGpPWpGaD
Trabectedin—SRC—Disease—MEN1—adrenal gland cancer	0.000443	0.000708	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	0.000442	0.000707	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—SDHD—adrenal gland cancer	0.000409	0.000654	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—RRM1—adrenal gland cancer	0.000409	0.000654	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—MED12—adrenal gland cancer	0.000408	0.000652	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000394	0.000631	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000385	0.000616	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—BAD—adrenal gland cancer	0.000372	0.000595	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—GNRH1—adrenal gland cancer	0.00037	0.000592	CbGpPWpGaD
Trabectedin—SRC—Immune System—PRKACA—adrenal gland cancer	0.000366	0.000585	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000365	0.000583	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—BAD—adrenal gland cancer	0.000357	0.000571	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000351	0.000562	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—EGFR—adrenal gland cancer	0.00034	0.000544	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SPRY2—adrenal gland cancer	0.000338	0.000541	CbGpPWpGaD
Trabectedin—SRC—Disease—PRKACA—adrenal gland cancer	0.000338	0.00054	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TSHR—adrenal gland cancer	0.00033	0.000527	CbGpPWpGaD
Trabectedin—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000329	0.000526	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.000316	0.000504	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.000316	0.000504	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDC42—adrenal gland cancer	0.000311	0.000497	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MEN1—adrenal gland cancer	0.00031	0.000496	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—EGFR—adrenal gland cancer	0.000308	0.000492	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—MED12—adrenal gland cancer	0.000305	0.000487	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PRKACA—adrenal gland cancer	0.000298	0.000476	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000294	0.000471	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000291	0.000465	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.00029	0.000464	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.00029	0.000464	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000288	0.00046	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000288	0.00046	CbGpPWpGaD
Trabectedin—SRC—Disease—CDC42—adrenal gland cancer	0.000287	0.000458	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—CTNNB1—adrenal gland cancer	0.000277	0.000443	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CTNNB1—adrenal gland cancer	0.000245	0.000391	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GNAS—adrenal gland cancer	0.000241	0.000386	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PRKACA—adrenal gland cancer	0.000237	0.000378	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ABCB1—adrenal gland cancer	0.000237	0.000378	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.000235	0.000376	CbGpPWpGaD
Trabectedin—SRC—Disease—TERT—adrenal gland cancer	0.00023	0.000368	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	0.000222	0.000356	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EGFR—adrenal gland cancer	0.00022	0.000351	CbGpPWpGaD
Trabectedin—SRC—Immune System—BAD—adrenal gland cancer	0.000217	0.000347	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000216	0.000346	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000214	0.000343	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00021	0.000336	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDC42—adrenal gland cancer	0.000201	0.000321	CbGpPWpGaD
Trabectedin—SRC—Disease—BAD—adrenal gland cancer	0.0002	0.00032	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EGFR—adrenal gland cancer	0.000194	0.00031	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IGF2—adrenal gland cancer	0.000194	0.000309	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—GNAS—adrenal gland cancer	0.000192	0.000307	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000192	0.000307	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.00019	0.000303	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.00019	0.000303	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IGF1R—adrenal gland cancer	0.000187	0.000299	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—EGFR—adrenal gland cancer	0.000186	0.000298	CbGpPWpGaD
Trabectedin—SRC—Disease—BRAF—adrenal gland cancer	0.000182	0.000291	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—adrenal gland cancer	0.000181	0.000289	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GNAS—adrenal gland cancer	0.00018	0.000288	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	0.000177	0.000283	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	0.000172	0.000274	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000168	0.000268	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—POMC—adrenal gland cancer	0.000162	0.00026	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TERT—adrenal gland cancer	0.000161	0.000258	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000158	0.000252	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000156	0.00025	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000153	0.000245	CbGpPWpGaD
Trabectedin—SRC—Disease—PTGS2—adrenal gland cancer	0.000147	0.000235	CbGpPWpGaD
Trabectedin—SRC—Immune System—CTNNB1—adrenal gland cancer	0.000143	0.000228	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000141	0.000226	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—BAD—adrenal gland cancer	0.00014	0.000224	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GNAS—adrenal gland cancer	0.000139	0.000222	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	0.000136	0.000218	CbGpPWpGaD
Trabectedin—SRC—Disease—CTNNB1—adrenal gland cancer	0.000132	0.00021	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTGS2—adrenal gland cancer	0.00013	0.000207	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—POMC—adrenal gland cancer	0.000129	0.000207	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000128	0.000205	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—BRAF—adrenal gland cancer	0.000128	0.000204	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000127	0.000203	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000126	0.000201	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000124	0.000199	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—POMC—adrenal gland cancer	0.000121	0.000194	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGFR—adrenal gland cancer	0.000113	0.000181	CbGpPWpGaD
Trabectedin—SRC—Disease—EGFR—adrenal gland cancer	0.000104	0.000167	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000103	0.000165	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	9.68e-05	0.000155	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—POMC—adrenal gland cancer	9.36e-05	0.00015	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CTNNB1—adrenal gland cancer	9.22e-05	0.000147	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—POMC—adrenal gland cancer	8.61e-05	0.000138	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—POMC—adrenal gland cancer	8.54e-05	0.000137	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GNAS—adrenal gland cancer	8.36e-05	0.000134	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	8.21e-05	0.000131	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	7.47e-05	0.000119	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGFR—adrenal gland cancer	7.3e-05	0.000117	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	6.87e-05	0.00011	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	6.81e-05	0.000109	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—adrenal gland cancer	6.13e-05	9.81e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—POMC—adrenal gland cancer	5.63e-05	9e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	4.49e-05	7.18e-05	CbGpPWpGaD
